The EPiC trial

This clinical trial aims to demonstrate the clinical and cost-utility of High-Flow Therapy (HFT), assessing the viability of home HFT as a suitable therapy for patients that have previously been hospitalised due to severe Chronic Obstructive Pulmonary Disease (COPD) exacerbation.

Study objectives*

The main objective of the trial is to investigate if home High-Flow Therapy (HFT) improves 12-month admission-free survival times, following a severe exacerbation of COPD requiring hospitalisation.

Patient population

Inclusion criteria icon

Main inclusion criteria

• Patients admitted to hospital with an exacerbation of COPD
• Age 40-80 years with smoking history >10 pack years
• Patient’s forced expiratory volume in 1 second (FEV1) is <80% predicted
• Patient’s FEV1/forced vital capacity (FVC) < 0.7

Study details

Study type icon

Study type

Prospective, multicentre, open-label, randomised, controlled trial with parallel groups.

Study investigators icon

Primary investigators

Prof Nicholas Hart
Dr Patrick Murphy

Lane Fox Clinical Respiratory Physiology, Research Centre, St Thomas Hospital

Sponsors icon


Guy’s and St Thomas’ Hospital NHS Foundation Trust

Study design

Study design icon

502 patients randomised into two groups:
• Intervention: Usual care + Home HFT
• Control: Usual care

Study timings icon

The enrolment period will last 24 months, with a follow-up period of 12 months, for a total study duration of 36 months.

The study endpoints

Primary endpoint:
12-month all cause admission-free survival

Secondary endpoints:
• Patient reported outcome measures (CAT, PSQI, EQ-5D-5L)**
• Physiological effects of HFT
• Cost utility analysis

14 proposed centres

Hear from the investigators

Learn more about this clinical trial from the investigator’s webpage.

This content is intended for health professionals only

* For more information visit the investigator’s research page

** CAT, computerised adaptive tests; PSQI, Pittsburgh sleep quality index; EQ-5D-5L, EuroQol 5-dimension, 5-level quality of life questionnaire.